Search research articles
Contact Us
Filters
Showing results (171-180 of 233) with videos related to
Page
of 24
Sort By:
Molecular Cancer Therapeutics
|
March 1, 2015
High turnover of tissue factor enables efficient intracellular delivery of antibody-drug conjugates
Bart E C G de Goeij, David Satijn, Claudia M Freitag, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 29, 2007
Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis
G H M van Puijvelde, T van Es, E J A van Wanrooij, et al.
European Journal of Immunology
|
September 5, 2024
Colony stimulating factor 1 receptor (Csf1r) expressing cell ablation in mafia (macrophage-specific Fas-induced apoptosis) mice alters monocyte landscape and atherosclerotic lesion characteristics
Indira Medina, Elias B Wieland, Lieve Temmerman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 31, 2013
Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display
Haixiang Yu, Filip Segers, Karen Sliedregt-Bol, et al.
Blood
|
September 23, 2006
Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment
Markus Lucerna, Alma Zernecke, Ramon de Nooijer, et al.
Biochemical Pharmacology
|
October 8, 2013
Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development
Marco van der Stoep, Zhaosha Li, Laura Calpe-Berdiel, et al.
Biochemical and Biophysical Research Communications
|
November 11, 2008
Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo
Willeke de Haan, Ruud Out, Jimmy F P Berbée, et al.
Circulation
|
October 3, 2007
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms
A O Kraaijeveld, S C A de Jager, W J de Jager, et al.
Cardiovascular Research
|
October 13, 2009
Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice
Kim L L Habets, Gijs H M van Puijvelde, Leonie M van Duivenvoorde, et al.
Biochemical Pharmacology
|
September 2, 2003
P-selectin as a candidate target in atherosclerosis
Tom J M Molenaar, Jaap Twisk, Sonja A M de Haas, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 233) with videos related to
Sort By:
Page
of 24
Molecular Cancer Therapeutics
|
March 1, 2015
High turnover of tissue factor enables efficient intracellular delivery of antibody-drug conjugates
Bart E C G de Goeij, David Satijn, Claudia M Freitag, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 29, 2007
Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis
G H M van Puijvelde, T van Es, E J A van Wanrooij, et al.
European Journal of Immunology
|
September 5, 2024
Colony stimulating factor 1 receptor (Csf1r) expressing cell ablation in mafia (macrophage-specific Fas-induced apoptosis) mice alters monocyte landscape and atherosclerotic lesion characteristics
Indira Medina, Elias B Wieland, Lieve Temmerman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 31, 2013
Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display
Haixiang Yu, Filip Segers, Karen Sliedregt-Bol, et al.
Blood
|
September 23, 2006
Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment
Markus Lucerna, Alma Zernecke, Ramon de Nooijer, et al.
Biochemical Pharmacology
|
October 8, 2013
Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development
Marco van der Stoep, Zhaosha Li, Laura Calpe-Berdiel, et al.
Biochemical and Biophysical Research Communications
|
November 11, 2008
Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo
Willeke de Haan, Ruud Out, Jimmy F P Berbée, et al.
Circulation
|
October 3, 2007
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms
A O Kraaijeveld, S C A de Jager, W J de Jager, et al.
Cardiovascular Research
|
October 13, 2009
Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice
Kim L L Habets, Gijs H M van Puijvelde, Leonie M van Duivenvoorde, et al.
Biochemical Pharmacology
|
September 2, 2003
P-selectin as a candidate target in atherosclerosis
Tom J M Molenaar, Jaap Twisk, Sonja A M de Haas, et al.
Page
of 24